|
|   |
Amgen, Inc.
| shareholder | country  % source |
|
| subsidiary | country  % source |
|
|
name  items photo compare the prices |
Shop local, ethical and at the best price on Ethishop ! |
|
|
« ETHICAL » RATING OF AMGEN
, group
and subsidiaries
[ ?] |
| Job: 14% of company's jobs cut since 1998 |
| Delinquency: 1 act(s) of financial or trade delinquency |
| Tax haven, secret bank account, shell companies: operates in 5 offshore financial center(s) |
| Sales: more than 12 billion(s) dollars/euros in annual sales |
| Net profit: more than 7 billion(s) dollars/euros in cumulated net profit since 1998 |
| Top management: earns 1054 times the median income in the United States (32000 US$/year) |
| Influence: 3 act(s) of direct corruption or lobbying |
|
|
Relevance: business & market share |
year | business source |
| 2006 | Amgen is the world's tenth-largest pharmaceutical group. | Les Echos |
| 2004 | Largest biotechnology group in the world. | Les Echos  |
|
World locations & Manufacturing |
year name | photo position; compensation source |
| 2006Morrow, Georges |  Vice-president; salary: 2.69 million US$; stock-options: 6.92 million US$; |
| 2005Danula, Richard D |  Chief Financial Officer; salary: 1.98 million US$; stock-options: 3.46 million US$; |
| 2005Sharer, Kevin W |  Chief Executive Officer; salary: 5.89 million US$; stock-options: 27.87 million US$; |
|
|
|
|
Also announce a documentary, a book or an article or comment this company profile.
Goal: present the company activities, improve the ethical rating's accuracy, develop an network of observers.